CH373386A - Process for the preparation of new 1,3-disubstituted phenothiazine derivatives - Google Patents
Process for the preparation of new 1,3-disubstituted phenothiazine derivativesInfo
- Publication number
- CH373386A CH373386A CH6724258A CH6724258A CH373386A CH 373386 A CH373386 A CH 373386A CH 6724258 A CH6724258 A CH 6724258A CH 6724258 A CH6724258 A CH 6724258A CH 373386 A CH373386 A CH 373386A
- Authority
- CH
- Switzerland
- Prior art keywords
- disubstituted
- formula
- preparation
- phenothiazine
- new
- Prior art date
Links
- -1 1,3-disubstituted phenothiazine Chemical class 0.000 title claims description 20
- 238000000034 method Methods 0.000 title claims description 4
- 238000002360 preparation method Methods 0.000 title claims description 4
- 229940066767 systemic antihistamines phenothiazine derivative Drugs 0.000 title claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- 125000000467 secondary amino group Chemical class [H]N([*:1])[*:2] 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 4
- XHQVXOJAZYFHQG-UHFFFAOYSA-N 1,3-dimethyl-10h-phenothiazine Chemical compound C1=CC=C2SC3=CC(C)=CC(C)=C3NC2=C1 XHQVXOJAZYFHQG-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229950000688 phenothiazine Drugs 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 1
- NYYRRBOMNHUCLB-UHFFFAOYSA-N 3-chloro-n,n-dimethylpropan-1-amine Chemical compound CN(C)CCCCl NYYRRBOMNHUCLB-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000002716 ataractic effect Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000002902 organometallic compounds Chemical class 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Description
Verfahren zur Herstellung von neuen 1,3-disubstituierten Phenothiazinabkömmlingen Gegenstand der Erfindung ist ein Verfahren zur Herstellung von 1,3-disubstituierten Phenothiazin- abkömmlin2en der Formel
EMI0001.0006
wobei X und Y gleiche oder verschiedene Alkyl- oder Alkoxylreste, wie Methyl- oder Methylreste, oder einer dieser Substituenten ein Halogenatom, vor zugsweise Chlor, A einen geraden oder verzweigten Alkylenrest mit 2-6 C-Atomen,
R1 und R2 gleiche oder verschiedene niedermolekulare Alkylreste be deuten, welche mit dem N-Atom ein heterocycli- sches Ringsystem, das noch ein weiteres Heteroatom enthalten kann, bilden können, das dadurch gekenn zeichnet ist, dass man 1,3-disubstituierte Phenothia- zine der Formel
EMI0001.0024
mit Aminoalkylhalogeniden der Formel
EMI0001.0026
wobei Hal ein Halogenatom bedeutet, oder 1,
3-di- substituierte Phenothiazine der Formel
EMI0001.0031
mit sekundären Aminen der Formel
EMI0001.0032
kondensiert. Als sekundäres Amin der Formel
EMI0001.0033
kann man z. B. Dimethylamin, Piperidin und ähn liche Verbindung verwenden.
Diese Verbindungen sind neu. Bei geringer Toxi- zität besitzen sie lokalanästhetische, sedative, ata- raktische und potenzierende Wirksamkeit, welche z. B. bei der Thiobarbituratnarkose besonders aus geprägt ist.
Die Kondensationen werden vorteilhaft in Gegen wart von säurebindenden Mitteln, z. B. Alkali metallen, ihren Hydroxyden, Amiden, Hydriden, Alkoholaten oder Organometallverbindungen und in einem inerten organischen Lösungsmittel, z. B. Xylol, durchgeführt. Die Kondensation verläuft auch ohne Lösungsmittel und ohne säurebindende Mittel.
Die Alkylaminoalkylhalogenide kann man auch in Form ihrer Salze mit starken Mineralsäuren verwenden, aber in diesem Falle ist ein Zusatz von säurebinden den Mitteln in entsprechender Menge erforderlich.
Die neuen, erfindungsgemäss dargestellten Verbin dungen können in Form ihrer wasserlöslichen Salze mit organischen oder anorganischen Säuren oder in Form wasserlöslicher Anlagerungsverbindungen verabreicht werden.
<I>Beispiel 1</I> Zu einer Lösung von 6,8 g 1,3-Dimethyl-pheno- thiazin (F. 147 C) in 40 ml Xylol setzt man 1,2 g fein zerriebenes Natriumamid 80%ig zu und erhitzt die Mischung unter Rühren 2 Stunden auf 130 C. Hierzu tropft man dann innerhalb 1 Stunde eine Lösung von 4 g 3-Dimethylaminopropylchlorid-1 in 20 ml Xylol und erhitzt dann die Reaktionsmischung weitere 2 Stunden auf l30 C.
Nach Abkühlen schüt telt man die Reaktionsmischung mit 20 ml einer 10%igen Salzsäurelösung aus, trennt die wässrige Schicht ab, macht sie mit konzentrierter Ammoniak lösung alkalisch und zieht sie zweimal mit je 20 ml Benzol aus. Man engt den Benzolauszug ein und destilliert den Rückstand unter vermindertem Druck. Man gewinnt das 1,3-Dimethyl-10-(3'-dimethyl- aminopropyl)-phenothiazin in Form einer hellgelben, viskosen Flüssigkeit. Kp2 = 178 C. Das Hydro- chlorid kann man z.
B. so darstellen, dass man die Base in gleicher Gewichtsmenge Chlorbenzol auf löst und dazu das Äquivalent einer wasserfreien ätherischen HCI-Lösung zusetzt. Das Hydrochlorid bildet farblose Nädelchen mit F. 169 C.
<I>Beispiel 2</I> Ersetzt man das 3-Dimethylaminopropylchlorid-1 in Beispiel 1 durch die äquivalente Menge von 2- Dimethylaminopropylchlorid-1, so erhält man das 1,3 -Dimethyl-10- (2'-dimethylamino-2'-methyläthyl)- phenothiazin im Gemisch mit seinem Isomeren, dem 1,3 -Dimethyl-10- (2'-dimethylamino-1'-methyläthyl)- phenothiazin [vgl. Charpentier und Duerot, C. r. 225, 306 (1947), 232, 415 (1951)].
Kp1,2 - 203-204 C (Base); das Hydrochlorid bildet farblose Kristalle (aus Chlorbenzol-Äther) mit F. 205 C (Zers.).
<I>Beispiel 3</I> Ersetzt man das 1,3-Dimethyl-phenothiazin in Beispiel 1 durch die äquivalente Menge von 3 Chlor-1-methyl-phenothiazin (F. 139-140 C), so erhält man das 3-Chlor-1-methyl-10-(3'-dimethyl- aminopropylaminopropyl)-phenothiazin. Die Base sie det bei 208 C/ 1 mm Hg; das Hydrochlorid schmilzt bei 177-178 C (Chlorbenzol).
<I>Beispiel 4</I> Ersetzt man das 1,3-Dimethyl-phenothiazin in Beispiel 1 durch die äquivalente Menge von 1-Chlor- 3-methoxy-phenothiazin (F. 132-133 C) und das 3-Dimethylaminopropylchlorid-1 durch die äquivalente. Menge von 2-Dimethylaminopropylchlorid-1, so er- hält man das 1-Chlor-3-methoxy-10-(2'-dimethyl- amino-2'-methyl-äthyl)-phenothiazin. Das Hydro- chlorid schmilzt bei 212 C.
Process for the preparation of new 1,3-disubstituted phenothiazine derivatives The invention relates to a process for the preparation of 1,3-disubstituted phenothiazine derivatives of the formula
EMI0001.0006
where X and Y are identical or different alkyl or alkoxyl radicals, such as methyl or methyl radicals, or one of these substituents is a halogen atom, preferably before chlorine, A is a straight or branched alkylene radical with 2-6 C atoms,
R1 and R2 denote identical or different low molecular weight alkyl radicals which, with the N atom, can form a heterocyclic ring system which can contain a further heteroatom, which is characterized in that 1,3-disubstituted phenothiazines are used the formula
EMI0001.0024
with aminoalkyl halides of the formula
EMI0001.0026
where Hal is a halogen atom, or 1,
3-disubstituted phenothiazines of the formula
EMI0001.0031
with secondary amines of the formula
EMI0001.0032
condensed. As a secondary amine of the formula
EMI0001.0033
you can z. B. use dimethylamine, piperidine and similar compound.
These connections are new. With low toxicity, they have local anesthetic, sedative, ataractic and potentiating effectiveness, which z. B. is particularly marked in thiobarbiturate anesthesia.
The condensations are advantageous in the presence of acid-binding agents such. B. alkali metals, their hydroxides, amides, hydrides, alcoholates or organometallic compounds and in an inert organic solvent, for. B. xylene performed. The condensation also takes place without solvents and without acid-binding agents.
The alkylaminoalkyl halides can also be used in the form of their salts with strong mineral acids, but in this case an addition of acid-binding agents in appropriate amounts is necessary.
The new compounds prepared according to the invention can be administered in the form of their water-soluble salts with organic or inorganic acids or in the form of water-soluble addition compounds.
<I> Example 1 </I> 1.2 g of finely ground 80% sodium amide are added to a solution of 6.8 g of 1,3-dimethylphenothiazine (mp 147 ° C.) in 40 ml of xylene The mixture is heated to 130 ° C. for 2 hours while stirring. A solution of 4 g of 3-dimethylaminopropyl chloride-1 in 20 ml of xylene is then added dropwise to this over the course of 1 hour and the reaction mixture is then heated to 130 ° C. for a further 2 hours.
After cooling, the reaction mixture is shaken out with 20 ml of a 10% strength hydrochloric acid solution, the aqueous layer is separated off, made alkaline with concentrated ammonia solution and extracted twice with 20 ml of benzene each time. The benzene extract is concentrated and the residue is distilled under reduced pressure. The 1,3-dimethyl-10- (3'-dimethylaminopropyl) phenothiazine is obtained in the form of a pale yellow, viscous liquid. Kp2 = 178 C. The hydrochloride can e.g.
B. represent that the base is dissolved in the same weight of chlorobenzene and the equivalent of an anhydrous ethereal HCI solution is added. The hydrochloride forms colorless needles with F. 169 C.
<I> Example 2 </I> If the 3-dimethylaminopropyl chloride-1 in Example 1 is replaced by the equivalent amount of 2-dimethylaminopropyl chloride-1, the 1,3-dimethyl-10- (2'-dimethylamino-2) is obtained '-methylethyl) - phenothiazine in a mixture with its isomer, the 1,3-dimethyl-10- (2'-dimethylamino-1'-methylethyl) - phenothiazine [cf. Charpentier and Duerot, C. r. 225, 306 (1947), 232, 415 (1951)].
Bp 1.2-203-204 C (base); the hydrochloride forms colorless crystals (from chlorobenzene ether) with a melting point of 205 ° C (decomp.).
<I> Example 3 </I> If the 1,3-dimethyl-phenothiazine in Example 1 is replaced by the equivalent amount of 3 chloro-1-methyl-phenothiazine (F. 139-140 C), the 3- Chloro-1-methyl-10- (3'-dimethyl-aminopropylaminopropyl) -phenothiazine. The base is at 208 ° C / 1 mm Hg; the hydrochloride melts at 177-178 C (chlorobenzene).
<I> Example 4 </I> If the 1,3-dimethyl-phenothiazine in Example 1 is replaced by the equivalent amount of 1-chloro-3-methoxyphenothiazine (F. 132-133 C) and the 3-dimethylaminopropyl chloride 1 by the equivalent. Amount of 2-dimethylaminopropyl chloride-1, 1-chloro-3-methoxy-10- (2'-dimethylamino-2'-methyl-ethyl) -phenothiazine is obtained. The hydrochloride melts at 212 C.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS494657 | 1957-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH373386A true CH373386A (en) | 1963-11-30 |
Family
ID=5393328
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH6724258A CH373386A (en) | 1957-12-20 | 1958-12-12 | Process for the preparation of new 1,3-disubstituted phenothiazine derivatives |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE573769A (en) |
| CH (1) | CH373386A (en) |
| NL (1) | NL106300C (en) |
-
1958
- 1958-12-10 BE BE573769A patent/BE573769A/en unknown
- 1958-12-12 NL NL234165A patent/NL106300C/en active
- 1958-12-12 CH CH6724258A patent/CH373386A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE573769A (en) | 1959-04-01 |
| NL106300C (en) | 1963-09-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2508045A1 (en) | SUBSTITUTED N- (1-BENZYLPYRROLIDINYL-2-ALKYL) BENZAMIDES, METHOD FOR THE PREPARATION AND MEDICINAL PRODUCTS CONTAINING THESE | |
| DE1018422B (en) | Process for the preparation of basic substituted heterocycles | |
| DE2426149B2 (en) | 7-Fluoro-substituted phenothiazines, processes for their preparation and pharmaceutical compositions containing them | |
| DE540697C (en) | Process for the preparation of diamines acylated on one side | |
| CH373386A (en) | Process for the preparation of new 1,3-disubstituted phenothiazine derivatives | |
| DE935546C (en) | Process for the preparation of N-acyl derivatives of iminodibenzyl | |
| CH509311A (en) | (A) Cmpds.:- (I) where R2 = H, lower alkyl, or lower alkenyl n = 2-4 A = (II) or (III) in which R and R1 and H, lower alkyl or halogen; | |
| DE2114884A1 (en) | Basically substituted derivatives of 1 (2H) -phthalazinone | |
| CH635834A5 (en) | DIBENZO (D, G) (1,3,6) DIOXAZOCIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THE MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS. | |
| DE1035150B (en) | Process for the preparation of N-monosubstituted ª ‡ - (tert-aminoalkyl) -ª ‡ -phenyl acetamides | |
| DE1136707B (en) | Process for the preparation of N-substituted azepines | |
| DE630842C (en) | Process for the preparation of acridine droplets | |
| DE3328186A1 (en) | BASIC ACETANILIDES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE ACETANILIDES | |
| DE881662C (en) | Process for the preparation of aminoalkyl ethers of diaryl carbinols | |
| AT151653B (en) | Process for the preparation of perhydrocarbazole derivatives. | |
| AT256116B (en) | Process for the preparation of new heterocyclic compounds | |
| AT217045B (en) | Process for the preparation of new monoalkylated or monohalogenated N-derivatives of 10,11-dihydro-5H-dibenzo [b, f] azepines and 5H-dibenzo [b, f] azepines | |
| DE1470173C (en) | 1 curly bracket on 3 ge curly bracket on square bracket on 5,6,7,8 Tetrahydro 4 (arylazo) 1 naphthyl square bracket on amino curly bracket on propyl curly bracket on piperidine compounds, their acid addition salts and process for their production | |
| DE953798C (en) | Process for the preparation of new disubstituted nicotinic acid amides | |
| DE1518652A1 (en) | Process for the preparation of pharmaceutically active derivatives of 2-aminoindane | |
| DE954424C (en) | Process for the preparation of alkylaminoalkyl esters of aminooxybenzoic acids | |
| DE954599C (en) | Process for the preparation of derivatives of 5-amino-8-methyl-thiochromanone and thiochromone | |
| AT311345B (en) | Process for the preparation of new, heterocyclic aminophenylalkylamines and of their acid addition salts | |
| CH310649A (en) | Process for the preparation of a 2-halo-4-aminotoluene. | |
| DEC0006830MA (en) |